Biopharma companies may want to pause before they plow ahead with their next acquisition. The costs are rising and...
Read moreAs inflation soars and pandemic-era aid comes to an end, many industries and Americans have been struggling to thrive in...
Read moreSanofi multiple sclerosis drug candidate tolebrutinib boasts a key feature: the ability to reach into brain and spinal cord...
Read moreAs Pride Month comes to a close, it is important to remember that members of the LGBTQ community still experience...
Read moreThe issues of choice and motherhood have dominated headlines over the past week. This discourse has centered around a woman’s...
Read moreThe federal government has reached a deal to pay $3.2 billion to secure a new supply of the Pfizer/BioNTech...
Read moreA recent webinar by Medable discussed steps it’s taking to improve clinical trial design through decentralized clinical trials (DCT). The...
Read moreThe highly fragmented nature of the home care sector often results in delayed access and frustration for seniors hoping to...
Read more“Technology is only as good as the impact it has on both patients and clinicians,” said Chris Altchek, founder and...
Read moreReCode Therapeutics was formed around new science potentially enabling delivery of genetic medicines to various organs in the body,...
Read moreCopyright ©️ All Rights Reserved | TimesNewsNetworks.com